Sign up to save your podcasts
Or
Share CNTF Treatment of MacTel2
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
CNTF Treatment of MacTel2
We discuss clinical trials using CNTF to treat MacTel Type 2 with Dr. John Pollack, Chief Medical Officer of Neurotech Pharmaceuticals.
View all episodes
By Retina Synthesis
4.5
88 ratings
We discuss clinical trials using CNTF to treat MacTel Type 2 with Dr. John Pollack, Chief Medical Officer of Neurotech Pharmaceuticals.
More shows like Retina Synthesis
View all
Straight From The Cutter's Mouth: A Retina Podcast
97 Listeners